Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 4, 2008, Pages 743-749

  Das, Swadesh K ^a   Hashimoto, Takashi ^a   Kanazawa, Kazuki ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Cell cycle arrest at G0 G1 phase; Cyclin D; Fucoxanthin; Hepatocarcinoma cell; Proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CAROTENOID; CYCLIN D; CYCLIN DEPENDENT KINASE 4; FUCOXANTHIN; PHOSPHOTRANSFERASE; PROTEASOME; PROTEASOME INHIBITOR; RETINOBLASTOMA PROTEIN; SERINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BROWN ALGA; CELL CYCLE ARREST; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CARCINOMA; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; G0 PHASE; G1 PHASE; GENE EXPRESSION; HUMANS; HYDROLYSIS; LIVER NEOPLASMS; MOLECULAR STRUCTURE; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; XANTHOPHYLLS;

ALGAE;

EID: 40949104695     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.01.003     Document Type: Article

References (52)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94 (2001) 153-156
2. Pham T.M., Fujino Y., Ide R., Kubo T., Shirane K., Tokui N., Mizoue T., Ogimoto I., Matsuda S., and Yoshimura T. Prospective study of vegetable consumption and liver cancer in Japan. Pham. Int. J. Cancer 119 (2006) 2408-2411
3. Sauvaget C., Nagano J., Allen N., and Kodama K. Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke 34 (2003) 2355-2360
4. La Vecchia C., Franceschi S., and Levi F. Epidemiological research on cancer with a focus on Europe. Eur. J. Cancer Prev. 12 (2003) 5-14
5. Slattery M.L., Benson J., Curtin K., Ma K.N., Schaeffer D., and Potter J.D. Carotenoids and colon cancer. Am. J. Clin. Nutr. 71 (2000) 575-582
6. Block G., Patterson B., and Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 18 (1992) 1-29
7. Le March L., Hankin J.H., Kolonel L.N., Beecher G.R., Wilkens L.R., and Zha L.P. Intake of specific carotenoids and lung cancer risk. Cancer Epidemiol. Biomark. Prev. 2 (1993) 183-187
8. Zhang S., Hunter D.J., Forman M.R., Rosner B.A., Speizer F.E., Colditz G.A., Manson J.E., Hankinson S.E., and Willett W.C. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 91 (1999) 547-556
9. Yu M.W., Chiu Y.H., Chiang Y.C., Chen C.H., Lee T.H., Santella R.M., Chern H.D., Liaw Y.F., and Chen C.J. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am. J. Epidemiol. 149 (1999) 621-629
10. Bishayee A., Sarkar A., and Chatterjee M. Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid. Nutr. Cancer 37 (2000) 89-98
11. Gradelet S., Le Bon A.M., Berges R., Suschetet M., and Astorg P. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism. Carcinogenesis 19 (1998) 403-411
12. Astorg P., Gradelet S., Berges R., and Suschetet M. Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr. Cancer 29 (1997) 60-68
13. Toledo L.P., Ong T.P., Pinho A.L., Jordao Jr. A., Vanucchi H., and Moreno F.S. Inhibitory effects of lutein and lycopene on placental glutathione S-transferase-positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepatocarcinogenesis. Nutr. Cancer 47 (2003) 62-69
14. Sherr C.J., and McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2 (2002) 103-112
15. Martin G.S. Cell signaling and cancer. Cancer Cell 4 (2003) 167-174
16. Hahn W. Cancer: surviving on the edge. Cancer Cell 6 (2004) 215-222
17. Muto Y., Moriwaki H., and Saito A. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N. Engl. J. Med. 340 (1999) 1046-1047
18. Takai K., Okuno M., Yasuda I., Matsushima-Nishiwaki R., Uematsu T., Tsurumi H., Shiratori Y., Muto Y., and Moriwaki H. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. Intervirology 48 (2005) 39-45
19. Suzui M., Masuda M., Lim J.T., Albanese C., Pestell R.G., and Weinstein I.B. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res. 62 (2002) 3997-4006
20. Qin L.F., and Ng I.O. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett. 175 (2002) 27-38
21. Yuan S., Zhang X., Lu L., Xu C., Yang W., and Ding J. Anticancer activity of methoxymorpholinyl doxorubicin (PNU 152243) on human hepatocellular carcinoma. Anticancer Drugs 15 (2004) 641-646
22. Maeda H., Hosokawa M., Sashima T., Takahashi N., Kawada T., and Miyashita K. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int. J. Mol. Med. 18 (2006) 147-152
23. Nishino H. Cancer prevention by natural carotenoids. Mutat. Res. 402 (1998) 159-163
24. Shiratori K., Ohgami K., Ilieva I., Jin X.H., Koyama Y., Miyashita K., Yoshida K., Kase S., and Ohno S. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp. Eye. Res. 81 (2005) 422-428
25. Das S.K., Hashimoto T., Shimizu K., Yoshida T., Sakai T., Sowa Y., Komoto A., and Kanazawa K. Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Biochim. Biophys. Acta 1726 (2005) 328-335
26. Das S.K., Hashimoto T., Baba M., Nishino H., Komoto A., and Kanazawa K. Japanese kelp (kombu) extract suppressed the formation of aberrant crypt foci in azoxymethane challenged mouse colon. J. Clin. Bio. Nutr. 38 (2006) 119-125
27. Okuzumi J., Takahashi T., Yamane T., Kitao Y., Inagake M., Ohya K., Nishino H., and Tanaka Y. Inhibitory effects of fucoxanthin, a natural carotenoid on N-ethyl-N′-nitro-N-nitrosoguanidine-induced mouse duodenal carcinogenesis. Cancer Lett. 68 (1993) 159-168
28. Kim D.J., Takasuka N., Kim J.M., Sekine K., Ota T., Asamoto M., Murakoshi M., Nishino H., Nir Z., and Tsuda H. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett. 120 (1997) 15-22
29. Kotake-Nara E., Kushiro M., Zhang H., Sugawara T., Miyashita K., and Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J. Nutr. 131 (2001) 3303-3306
30. Hosokawa M., Wanezaki S., Miyauchi K., Kurihara H., Kohno H., Kawabata J., Odashima S., and Takahashi K. Apoptosis-inducing effect of fucoxanthin on human leukemia cell HL-60. Food Sci. Technol. Res. 5 (1999) 243-246
31. Hosokawa M., Kudo M., Maeda H., Kohno H., Tanaka T., and Miyashita K. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARγ ligand, troglitazone, on colon cancer cells. Biochim. Biophys. Acta 1675 (2004) 113-119
32. Okuzumi J., Nishino H., Murakoshi M., Iwashima A., Tanaka Y., Yamane T., Fujita Y., and Takahashi T. Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Lett. 55 (1990) 75-81
33. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., and Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89 (1997) 1881-1886
34. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
35. Sugimoto M., Martin N., Wilks D.P., Tamai K., Huot T.J., Pantoja C., Okumura K., Serrano M., and Hara E. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). Oncogene 21 (2002) 8067-8074
36. Obaya A.J., Kotenko I., Cole M.D., and Sedivy J.M. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. J. Biol. Chem. 277 (2002) 31263-31269
37. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., and Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78 (1994) 761-771
38. Uchimaru K., Taniguchi T., Yoshikawa M., Asano S., Arnold A., Fujita T., and Motokura T. Detection of cyclin D1 (bcl-1, PRAD1) over-expression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 89 (1997) 965-974
39. Kitagawa M., Higashi H., Jung H.K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshida E., Nishimura S., and Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15 (1996) 7060-7069
40. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
41. Diehl J.A., Zindy F., and Sherr C.J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11 (1997) 957-972
42. Sherr C.J. G1 phase progression: cycling on cue. Cell 79 (1994) 551-555
43. Diehl J.A., Cheng M., Roussel M.F., and Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12 (1998) 3499-3511
44. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30 (1996) 405-439
45. Alao J.P., Stavropoulou A.V., Lam E.W., Coombes R.C., and Vigushin D.M. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Mol. Cancer (2006) 5-8
46. Huang J.W., Shiau C.W., Yang Y.T., Kulp S.K., Chen K.F., Brueggemeier R.W., Shapiro C.L., and Chen C.S. Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol. Pharmacol. 67 (2005) 1342-1348
47. Langenfeld J., Kiyokawa H., Sekula D., Boyle J., and Dmitrovsky E. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12070-12074
48. Dragnev K.H., Pitha-Rowe I., Ma Y., Petty W.J., Sekula D., Murphy B., Rendi M., Suh N., Desai N.B., Sporn M.B., Freemantle S.J., and Dmitrovsky E. Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy. Clin. Cancer Res. 10 (2004) 2570-2577
49. Yoshiko S., and Nishino H. Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. In vivo 21 (2007) 305-310
50. Smith M.L., Chen I.T., Zhan Q., Bae I., Chen C.Y., Gilmer T.M., Kastan M.B., O'Connor P.M., and Fornace Jr. A.J. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266 (1994) 1376-1380
51. Vairapandi M., Balliet A.G., Fornace Jr. A.J., Hoffman B., and Liebermann D.A. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. Oncogene 12 (1996) 2579-259
52. Ji J., Liu R., Tong T., Song Y., Jin S., Wu M., and Zhan Q. Gadd45a regulates beta-catenin distribution and maintains cell-cell adhesion/contact. Oncogene 26 (2007) 6396-6405